MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
MicroRNAs comprise a broad class of small non-coding RNAs that control expression of complementary target messenger RNAs. Dysregulation of microRNAs by several mechanisms has been described in various disease states including cardiac disease. Whereas previous studies of cardiac disease have focused on microRNAs that are primarily expressed in cardiomyocytes, the role of microRNAs expressed in other cell types of the heart is unclear. Here we show that microRNA-21 (miR-21, also known as Mirn21) regulates the ERK-MAP kinase signalling pathway in cardiac fibroblasts, which has impacts on global cardiac structure and function. miR-21 levels are increased selectively in fibroblasts of the failing heart, augmenting ERK-MAP kinase activity through inhibition of sprouty homologue 1 (Spry1). This mechanism regulates fibroblast survival and growth factor secretion, apparently controlling the extent of interstitial fibrosis and cardiac hypertrophy. In vivo silencing of miR-21 by a specific antagomir in a mouse pressure-overload-induced disease model reduces cardiac ERK-MAP kinase activity, inhibits interstitial fibrosis and attenuates cardiac dysfunction. These findings reveal that microRNAs can contribute to myocardial disease by an effect in cardiac fibroblasts. Our results validate miR-21 as a disease target in heart failure and establish the therapeutic efficacy of microRNA therapeutic intervention in a cardiovascular disease setting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epigenetic manipulation through long non-coding RNAs, miRNA modulators, and other oligonucleotides has yielded promising outcomes in experimental settings.162–165”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [162]
Citations
Cites
1 retracted
Rockman, H. A., Ross, R. S., Harris, A. N., Knowlton, K. U., Steinhelper, M. E., Field, L. J., Ross, J., & Chien, K. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8277 · Cited by 797
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Self-citationA microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
MicroRNA-133 controls cardiac hypertrophy
Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.-L., Segnalini, P., Gu, Y., Dalton, N. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1582 · Cited by 1,776
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Yang, B., Lin, H., Xiao, J., Lu, Y., Luo, X., Li, B., Zhang, Y., Xu, C., Bai, Y., Wang, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1569 · Cited by 1,138
Cited by
Items 801–900 of 1,006
miR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1
Li, S., Geng, J., Xu, X., Huang, X., Leng, D., Jiang, D., Liang, J., Wang, C., Jiang, D., & Dai, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150418 · Cited by 59
MicroRNAs in lipid metabolism and atherosclerosis
Giral, H., Kratzer, A., & Landmesser, U. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.11.010 · Cited by 61
England, J. C., Granados-Riveron, J. T., Polo‐Parada, L., Kuriakose, D., Moore, C., Brook, J. D., Rutland, C. S., Setchfield, K., Gell, C., Ghosh, T. K., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.03.006 · Cited by 69
“25 MircroRNA-21 plays a role in cardiac disease, and impairment of its function resulted in regression of 26 cardiac hypertrophy and fibrosis in a mouse model of left ventricular overload [52].”
BackgroundCardiac Thyroid Hormone Metabolism and Heart Failure
Janssen, R., Muller, A., & Simonides, W. S. (2017) · European Thyroid Journal · doi:10.1159/000469708 · Cited by 58
MicroRNAs Regulating Reactive Oxygen Species in Cardiovascular Diseases
Gong, Y.-Y., Luo, J., Wang, L., & Huang, Y. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7328 · Cited by 57
Pharmacokinetics and Proceedings in Clinical Application of Nucleic Acid Therapeutics
Herkt, M., & Thum, T. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.008 · Cited by 56
“The knockdown of miR-21 with antimiRs also prevents cardiac hypertrophy and additionally can even reverse interstitial fibrosis after TAC.(102) A validation study was done in large animals after MI.”
BackgroundSelf-citationLi, X., Li, L., Lei, W., Chua, H. Z., Li, Z., Huang, X., Wang, Q., Li, N., & Zhang, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111979 · Cited by 59
Cardiorenal syndrome: long road between kidney and heart
Junho, C. V. C., Sonoda, M. T., Panico, K., Neres-Santos, R. S., Abrahão, M., Vernier, I. C. S., Fürstenau, C. R., & Carneiro‐Ramos, M. S. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10218-w · Cited by 68
“During renal inflammation, IL-6 and extracellular vesicles secreted by macrophages induce miR-21 in renal fibroblasts [122].”
BackgroundMyocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
Lunde, I. G., Rypdal, K. B., Linthout, S. V., Díez, J., & González, A. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.08.008 · Cited by 68
Bish, L. T., Sleeper, M. M., Reynolds, C., Gazzara, J. A., Withnall, E., Singletary, G. E., Buchlis, G., Hui, D. J., High, K. A., Gao, G., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.035 · Cited by 66
“In doing so, they regulate expression of genes involved in multiple processes, such as hypertrophy (van Rooij et al. , 2007), conduction (Callis et al. , 2009), fibrosis (Thum et al. , 2008b), and apoptosis (Rane et al. , 2009).”
Cardioprotective Effect of Micro RNA ‐21 in Murine Myocardial Infarction
Gu, G., Xu, X., Sun, X., Zhang, J., Guo, C., Wang, C., Sun, B., Guo, G., Ma, K., Huang, Y., et al. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12118 · Cited by 55
Epigenetic mechanisms underlying cardiac degeneration and regeneration
Chaturvedi, P., & Tyagi, S. C. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.02.008 · Cited by 71
“miR-21 Antagomir-21 decreased the development of cardiac fibrosis and improved cardiac function [189-191]”
BackgroundMicroRNA-21 regulation of the progression of viral myocarditis to dilated cardiomyopathy
XU, H.-F., DING, Y.-J., ZHANG, Z.-X., WANG, Z.-F., LUO, C.-L., LI, B.-X., SHEN, Y.-W., TAO, L.-Y., & ZHAO, Z.-Q. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2205 · Cited by 54
“Thum et al identified that SPRY1 was a direct target of miRNA-21 and mediated the effect of miRNA‑21 in cardiac fibroblasts (18).”
Wagenaar, T. R., Tolstykh, T., Shi, C., Jiang, L., Zhang, J., Li, Z., Yu, Q., Qu, H., Sun, F., Cao, H., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1367 · Cited by 56
Cengız, M., Karataş, Ö. F., Koparir, E., Yavuzer, S., Ali, C., Yavuzer, H., Kırat, E., Karter, Y., & Özen, M. (2015) · Medicine · doi:10.1097/md.0000000000000693 · Cited by 57
McDonnell, F. S., Irnaten, M., Clark, A. F., O'Brien, C. J., & Wallace, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153354 · Cited by 61
Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease
Zhang, L., Zhang, Y., Zhao, Y., Wang, Y., Ding, H., Xue, S., & Li, P. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1503650 · Cited by 58
Polymer nanocarriers for MicroRNA delivery
Kapadia, C. H., Luo, B., Dang, M. N., Irvin-Choy, N. S., Valcourt, D. M., & Day, E. S. (2019) · Journal of Applied Polymer Science · doi:10.1002/app.48651 · Cited by 62
Sharma, S. B., Lin, C., Farrugia, M. K., McLaughlin, S. L., Ellis, E. J., Brundage, K. M., Salkeni, M. A., & Ruppert, J. M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00480-14 · Cited by 63
MicroRNA-337 is associated with chondrogenesis through regulating TGFBR2 expression.
Zhong, N., Sun, J., Min, Z., Zhao, W., Zhang, R., Wang, W., Tian, J., Tian, L.-F., Ma, J., Li, D.-M., et al. (2012) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.03.002 · Cited by 58
Sun, Y. L., Ge, Y., Fu, Y., Yan, L., Cai, J., Shi, K., Cao, X., & Lu, C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.002 · Cited by 56
Meganathan, K., Sotiriadou, I., Natarajan, K., Hescheler, J., & Sachinidis, A. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.049 · Cited by 57
“The key role of miRNAs, includingmiR-21, miR-24, miR-221/222, miR-143 and miR-145 have been revealed in the control of cardiac and skeletal muscle development and remodeling in response to injury, and in the regulation of the gene expression in SMC [181–184].”
BackgroundNon-viral nanovectors for gene delivery: factors that govern successful therapeutics
Viola, J. R., Andaloussi, S. E., Oprea, I. I., & Smith, C. E. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003716810 · Cited by 63
“[66,67].”
Nishi, H., Sakaguchi, T., Miyagawa, S., Yoshikawa, Y., Fukushima, S., Saito, S., Ueno, T., Kuratani, T., & Sawa, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073397 · Cited by 53
“MiRNAs are also considered to be related with regulation of fibrosis and apoptosis of cardiomyocytes [16-18].”
BackgroundZhu, H., Luo, H., & Zuo, X. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.71 · Cited by 56
MicroRNAs as new players in the pain game
Niederberger, E., Kynast, K., Lötsch, J., & Geisslinger, G. (2011) · Pain · doi:10.1016/j.pain.2011.01.042 · Cited by 53
“[33], who showed that miRNA-21 is selectively increased in fibroblasts of the failing heart.”
Differential expression of microRNAs in ischemic heart disease
Song, M., Paradis, A. N., Gay, M. S., Shin, J. Y., & Zhang, L. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.004 · Cited by 54
“miR-21 targets sprout homolog 1 (Spry1), a potent inhibitor of ERK/MAPK signaling, which promotes the secretion of fibroblast growth factor 2 (FGF2) [48,69].”
BackgroundThe role of the miR-31 /FIH1 pathway in TGF-β-induced liver fibrosis
Hu, J., Chen, C., Liu, Q., Liu, B., Song, C., Zhu, S., Wu, C., Liu, S., Yu, H., Yao, D., et al. (2015) · Clinical Science · doi:10.1042/cs20140012 · Cited by 58
Qi, W., Li, H., Cai, X., Gu, J.-Q., Meng, J., Xie, H.-Q., Zhang, J., Chen, J., Jin, X.-G., Tang, Q., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.109 · Cited by 53
Identification of cardiac long non-coding RNA profile in human dilated cardiomyopathy
Li, H., Chen, C., Fan, J., Yin, Z., Ni, L., Cianflone, K., Wang, Y., & Wang, D. W. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy012 · Cited by 55
MicroRNA-143-3p promotes human cardiac fibrosis via targeting sprouty3 after myocardial infarction
Li, C., Li, J., Xue, K., Zhang, J., Wang, C., Zhang, Q., Chen, X., Gao, C., Yu, X., & Sun, L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.03.005 · Cited by 58
Lange, T., Artelt, N., Kindt, F., Stracke, S., Rettig, R., Lendeckel, U., Chadjichristos, C. E., Kavvadas, P., Chatziantoniou, C., Endlich, K., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14317 · Cited by 53
Hromadníková, I., Kotlabová, K., Dvořáková, L., & Krofta, L. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.05.036 · Cited by 58
Cell type–specific microRNA therapies for myocardial infarction
Liu, B., Wang, B., Zhang, X., Lock, R., Nash, T., & Vunjak-Novakovic, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd0914 · Cited by 53
Galluzzo, A., Gallo, S., Pardini, B., Birolo, G., Fariselli, P., Boretto, P., Vitacolonna, A., Neia, C. P., Spilinga, M., Volpe, A., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13371 · Cited by 58
Baumgarten, A., Bang, C., Tschirner, A., Engelmann, A., Adams, V., von Haehling, S., Doehner, W., Pregla, R., Anker, M. S., Blecharz, K., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.094 · Cited by 55
“Recently, several microRNAs, which are endogenous, small non-codingRNAs that negatively control expressionof complementary target messenger RNAs, have been implicated in heart failure [3,4].”
BackgroundMethodSelf-citationDeng, X., Zhong, Y., Gu, L.-Z., Shen, W., & Guo, J. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.02.007 · Cited by 53
Silvestri, P., Russo, C. D., Rigattieri, S., Fedele, S., Todaro, D., Ferraiuolo, G., ALTAMURA, G., & Loschiavo, P. (2009) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489009788452977 · Cited by 64
Circulating MicroRNAs Are Not Eliminated by Hemodialysis
Martino, F., Lorenzen, J. M., Schmidt, J. J., Schmidt, M., Broll, M., Görzig, Y., Kielstein, J. T., & Thum, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038269 · Cited by 55
Self-citationRegulation of T lymphocyte activation by microRNA-21
Wang, L., He, L., Zhang, R., Liu, X., Ren, Y., Liu, Z., Zhang, X., Cheng, W., & Hua, Z.-C. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.02.004 · Cited by 56
Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts
Jiang, X., Ning, Q., & Wang, J. (2012) · The Journal of Physiological Sciences · doi:10.1007/s12576-012-0230-y · Cited by 52
Androsavich, J. R., Chau, B. N., Bhat, B., Linsley, P. S., & Walter, N. G. (2012) · RNA · doi:10.1261/rna.033308.112 · Cited by 59
“2006) as well as heart fibroblasts following cardiac stress (Thum et al. 2008).”
BackgroundSchuster, I., Mahmoodzadeh, S., Dworatzek, E., Jaisser, F., Messaoudi, S., Morano, I., & Regitz-Zagrosek, V. (2016) · Clinical Science · doi:10.1042/cs20150609 · Cited by 51
“Silencing of miR-21 in different HF models led to the suppression of cardiac fibrosis, collagen and periostin expression and attenuation of cardiac dysfunction [36-38].”
BackgroundNing, J., Zhang, H., & Yang, H. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9187 · Cited by 65
“Previous studies revealed that aberrant expression or dysfunction of miRNAs has an important role in various types of tissue fibrosis, such as in the heart (17,18), kidney (19,20), liver (21) and lung (22).”
MicroRNAs in Vascular Eye Diseases
Liu, C., Huang, S., Britton, W. R., & Chen, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020649 · Cited by 60
MicroRNA-21-3p Engineered Umbilical Cord Stem Cell-Derived Exosomes Inhibit Tendon Adhesion
Yao, Z., Li, J., Wang, X., Peng, S., Ning, J., Qian, Y., & Fan, C. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s254879 · Cited by 55
Carbon nanodot–based electrogenerated chemiluminescence biosensor for miRNA-21 detection
Gutiérrez-Gálvez, L., García‐Mendiola, T., Gutiérrez‐Sánchez, C., Guerrero-Esteban, T., García-Diego, C., Buendía, I., García‐Bermejo, L., Pariente, F., & Lorenzo, E. (2021) · Microchimica Acta · doi:10.1007/s00604-021-05038-y · Cited by 52
Nonviral gene therapy targeting cardiovascular system
Su, C., Wu, Y., Wang, H.-H., & Yeh, H. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00126.2012 · Cited by 60
Targeting miR-21 in glioma: a small RNA with big potential
Moore, L. M., & Zhang, W. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.527334 · Cited by 51
“Other targets which have been identified in other cell types but not yet confirmed in glioma include FasL, sprouty homologue 1 (Spry1), Cdc25a, B-cell translocation gene 2 (BTG2), bone morphogenic protein receptor, type II (BMPRII), myristoylated alanine-rich protein kinase C substrate (MARCKS), and ras homolog gene f…”
BackgroundInfluentialYe, X., Zhang, H. M., Qiu, Y., Hanson, P. J., Hemida, M. G., Wei, W., Hoodless, P. A., Chu, F., & Yang, D. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004070 · Cited by 51
“suppression of miR-21 affects the morphology, size or number of cardiomyocytes in primary culture [10], while another group”
BackgroundSTAT3 regulation of and by microRNAs in development and disease
Haghikia, A., Ricke‐Hoch, M., Stapel, B., & Hilfiker‐Kleiner, D. (2012) · JAK-STAT · doi:10.4161/jkst.19573 · Cited by 56
MicroRNA modulate alveolar epithelial response to cyclic stretch
Yehya, N., Yerrapureddy, A., Tobias, J. W., & Margulies, S. S. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-154 · Cited by 52
“MiRNAs are involved in the hypoxic response of many cell types [21-24] and the post-infarct myocardium [25-27], and also in the fibrotic response after ischemia/reperfusion [28,29], consistent with their role as modifiers of tissue injury and healing.”
BackgroundMicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
Vanas, V., Haigl, B., Stockhammer, V., & Sutterlüty, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161023 · Cited by 52
“Many miR-21 targets code for tumor suppressors, with a role in inhibiting cell signaling, cell proliferation and migration, e.g. phosphatase and tensin homolog (PTEN) tumor suppressor [13], Sprouty1 (Spry1) [15] and Sprouty2 [16].”
BackgroundInfluentialLi, Y., Cao, R., Liu, Y., Wang, L.-Z., Pan, B., Lv, X., Jiao, H., Zhuang, Q., Sun, X., & Xiao, R. (2016) · Scientific Reports · doi:10.1038/srep28281 · Cited by 51
Subramanian, V., Seemann, I., Merl‐Pham, J., Hauck, S. M., Stewart, F., Atkinson, M. J., Tapio, S., & Azimzadeh, O. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00795 · Cited by 53
Noncoding RNAs in Wound Healing: A New and Vast Frontier
Luan, A., Hu, M. S.-M., Leavitt, T., Brett, E. A., Wang, K., Longaker, M. T., & Wan, D. C. (2018) · Advances in Wound Care · doi:10.1089/wound.2017.0765 · Cited by 52
“conjugated anti-miRNA-21 to cholesterol and successfully delivered the oligonucleotide to fibroblasts, with the result of reduced interstitial fibrosis and cardiac dysfunction.(53) lncRNAs may also be targeted for inhibition or delivered for exogenous expression.”
BackgroundmiR-21 suppression prevents cardiac alterations induced by d-galactose and doxorubicin
Bei, Y., Wu, X., Crețoiu, D., Shi, J., Zhou, Q., Lin, S., Wang, H., Cheng, Y., Zhang, H., Xiao, J., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.01.007 · Cited by 56
Emerging Role of mTOR Signaling‐Related miRNAs in Cardiovascular Diseases
Samidurai, A., Kukreja, R. C., & Das, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6141902 · Cited by 51
miR-107 inhibits CDK6 expression, differentiation, and lipid storage in human adipocytes
Ahonen, M. A., Haridas, P. A. N., Mysore, R., Wabitsch, M., Fischer‐Posovszky, P., & Olkkonen, V. M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.09.007 · Cited by 52
Bollini, S., Smits, A. M., Balbi, C., Lazzarini, E., & Ameri, P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01497 · Cited by 53
“A pioneering study conducted in 2007 demonstrated the ability of cultured adult cardiomyocytes to secrete Ex containing HSP60, which is involved in regulation of cardiomyocytes apoptosis and inflammation and, therefore, may play a primary role in myocardial pathology (Tian et al., 2013).”
BackgroundEpigenetics and microRNAs in cardiovascular diseases
Colpaert, R. M. W., & Calore, M. (2021) · Genomics · doi:10.1016/j.ygeno.2020.12.042 · Cited by 54
MicroRNAs and Mesenchymal Stem Cells
Collino, F., Bruno, S., Deregibus, M. C., Tetta, C., & Camussi, G. (2011) · Vitamins and hormones · doi:10.1016/b978-0-12-386015-6.00033-0 · Cited by 54
miRNAs as Therapeutic Targets in Ischemic Heart Disease
Frost, R., & van Rooij, E. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9173-y · Cited by 55
“[15] showed an increase of the fibroblast-enriched miR-21 in the failing and hypertrophic heart most likely as a consequence of fibroblast proliferation.”
Jayawardena, E., Medzikovic, L., Ruffenach, G., & Eghbali, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031512 · Cited by 55
“MAP kinase signaling pathway via inhibition of Spry1 [65].”
BackgroundInfluentialAberrant miR-21 and miR-200b expression and its pro-fibrotic potential in hypertrophic scars
Zhou, R., Zhang, Q., Zhang, Y., Fu, S., & Wang, C. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.018 · Cited by 54
Molecular events in matrix protein metabolism in the aging kidney
Sataranatarajan, K., Féliers, D., Mariappan, M. M., Lee, H. J., Lee, M. J., Day, R. T., Yalamanchili, H. B., Choudhury, G. G., Barnes, J. L., Remmen, H. V., et al. (2012) · Aging Cell · doi:10.1111/acel.12008 · Cited by 53
Glycoprotein 130 Cytokine Signal as a Therapeutic Target Against Cardiovascular Diseases
Fujio, Y., Maeda, M., Mohri, T., Obana, M., Iwakura, T., Hayama, A., Yamashita, T., Nakayama, H., & Azuma, J. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11r05cr · Cited by 53
MicroRNAs in platelet biogenesis and function
Dangwal, S., & Thum, T. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0211 · Cited by 51
Self-citationHirschy, A., Croquelois, A., Perriard, E. R., Schoenauer, R., Agarkova, I., Hoerstrup, S. P., Taketo, M. M., Pedrazzini, T., Perriard, J., & Ehler, E. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0101-8 · Cited by 51
“Recent work by the Engelhardt laboratory has once more pointed out that deductions from whole heart tissue can be slightly misleading since it may actually be signalling events in cardiac fibroblasts that lead to a particular readout in the entire tissue [44].”
BackgroundSandhu, H., & Maddock, H. L. (2013) · Clinical Science · doi:10.1042/cs20120620 · Cited by 57
Muth, M., Theophile, K., Hussein, K., Jacobi, C., Kreipe, H. H., & Bock, O. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-33 · Cited by 53
“However, it has recently been shown by a decisive study that overexpression of miRNA-21 in fibroblasts is involved in myocardial fibrosis [14] suggesting that stress signaling could affect miRNA expression.”
Dai, W., Zhao, J., Tang, N., Zeng, X. Y., Wu, K., Ye, C., Shi, J. G., Lu, C., Ning, B., Zhang, J., et al. (2014) · Liver International · doi:10.1111/liv.12660 · Cited by 52
“RNA isolation, quantitative real-time PCR and Western blot analysis Total RNA was extracted from cells, tissues or sera using Trizol reagent (Takara, Dalian, China).”
MethodInfluentialJasinski‐Bergner, S., Reches, A., Stoehr, R., Massa, C., Gonschorek, E., Hüttelmaier, S., Braun, J., Wach, S., Wullich, B., Spath, V., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8567 · Cited by 50
“Recently, the implementation of miRs or antagomiRs have been suggested as novel therapeutic options against various human diseases including cardiovascular diseases [38, 39], viral infections [40] and tumors [41].”
BackgroundMarsh, E. E., Steinberg, M. L., Parker, J. B., Wu, J., Chakravarti, D., & Bulun, S. E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.001 · Cited by 52
“(28) found that miRNA-30 targets connective tissue growth factor, whereas Thum and colleagues (29) demonstrated that miRNA21 targets sprout1 and regulated fibroblast survival.”
BackgroundThe role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis
Chen, X., Shi, C., Wang, C., Liu, W., Chu, Y., Xiang, Z., Hu, K., Dong, P., & Han, X. (2017) · Scientific Reports · doi:10.1038/srep40958 · Cited by 52
Myocardial microRNAs associated with reverse remodeling in human heart failure
Sucharov, C. C., Kao, D. P., Port, J. D., Karimpour‐Fard, A., Quaife, R. A., Minobe, W. A., Nunley, K. R., Lowes, B. D., Gilbert, E. M., & Bristow, M. R. (2017) · JCI Insight · doi:10.1172/jci.insight.89169 · Cited by 54
“Furthermore, in a mouse model of isoproterenol infusion, downregulation of miR-21 prevented cardiac dysfunction (32).”
BackgroundBerezin, A. Е., & Berezin, A. A. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00047 · Cited by 53
Ye, H., Ling, S., Castillo, A. C., Thomas, B., Long, B., Qian, J., Perez-Polo, J. R., Ye, Y., Chen, X., & Birnbaum, Y. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00892 · Cited by 54
Atrial myocyte-derived exosomal microRNA contributes to atrial fibrosis in atrial fibrillation
Hao, H., Yan, S. R., Zhao, X., Han, X., Fang, N., Zhang, Y., Dai, C., Li, W., Yu, H., Gao, Y., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03617-y · Cited by 54
“Several miRNAs play critical roles in hypertrophic and fibrotic myocardial tissues, suggesting an association between specific miRNA levels and the development of pathological cardiac remodeling [36, 37].”
BackgroundWang, Y., Ouyang, W., Pan, Q., Wang, X., Xia, X., Bi, Z., Wang, Y.-Q., & Wang, X. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.001 · Cited by 53
MiR-346 regulates CD4+CXCR5+ T cells in the pathogenesis of Graves’ disease
Chen, J., Tian, J., Tang, X., Rui, K., Ma, J., Mao, C., Liu, Y., Lu, L., Xu, H., & Wang, S. (2015) · Endocrine · doi:10.1007/s12020-015-0546-5 · Cited by 52
Small Engine, Big Power: MicroRNAs as Regulators of Cardiac Diseases and Regeneration
Joladarashi, D., Thandavarayan, R. A., Babu, S. S., & Krishnamurthy, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150915891 · Cited by 53
“augments extracellular signal-regulated kinase/mitogen-activated protein kinase signaling [77] or increased MMP-2 expression via decreased phosphatase and tensin homologue (PTEN) [78], leading to fibroblast proliferation and fibrosis.”
BackgroundErdem, A., Çongur, G., & Ekşin, E. (2013) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2013.07.114 · Cited by 55
Regulatory roles of microRNA-21 in fibrosis through interaction with diverse pathways (Review)
Liu, R., Ning, B., MA, X.-E., Gong, W.-M., & Jia, T. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4834 · Cited by 53
“In addition, aberrantly expressed miR‑21 has been found to promote fibrogenic activation of fibroblasts (33,34). miR‑21 is able to regulate protein expression in multiple organs and tissues and has an impact on tumor development, cancer, inflammation and the immune system (30,35-38).”
Beaumont, J., López, B., Ravassa, S., Hermida, N., José, G. S., Gallego, I., Valencia, F., Gómez‐Doblas, J. J., de Teresa, E., Díez, J., et al. (2017) · Scientific Reports · doi:10.1038/srep40696 · Cited by 55
MicroRNAs as Potential Pharmaco-Targets in Ischemia-Reperfusion Injury Compounded by Diabetes
Dehaini, H., Awada, H., EL‐Yazbi, A. F., Zouein, F. A., Issa, K., Eid, A. A., Ibrahim, M., Badran, A., Baydoun, E., Pintus, G., et al. (2019) · Cells · doi:10.3390/cells8020152 · Cited by 50
Puglisi, R., Mattia, G., Carè, A., Marano, G., Malorni, W., & Matarrese, P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00733 · Cited by 53
Makkos, A., Ágg, B., Petrovich, B., Varga, Z. V., Görbe, A., & Ferdinandy, P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.034 · Cited by 54
Wang, Z., Li, D., Tian, X., & Zhang, C. (2021) · Chemical Science · doi:10.1039/d1sc01865e · Cited by 49
The role of MicroRNAs in tendon injury, repair, and related tissue engineering
Liu, Q., Zhu, Y., Zhu, W., Zhang, G., Yang, Y., & Zhao, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121083 · Cited by 49
Gaede, L., Liebetrau, C., Blumenstein, J., Troidl, C., Dörr, O., Kim, W., Gottfried, K., Voss, S., Berkowitsch, A., Walther, T., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw007 · Cited by 49
“The upregulation of miR-21 in response to cardiac injury protects fibroblasts against apoptosis, which results in left ventricular interstitial fibrosis and haemodynamic dysfunction [18].”
BackgroundEpigenetics as a versatile regulator of fibrosis
Liu, Y., Wen, D., Ho, C., Li, Y., Zheng, D., O’Reilly, S., Gao, Y., Li, Q., & Zhang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04018-5 · Cited by 55
“injection of a specific antisense microribonucleic acid against miR-21 can lead to the regression of cardiac fibrosis [213, 214].”
BackgroundNonaka, C. K. V., Sampaio, G. L. D. A., França, L. S. D. A., Cavalcante, B. R. R., da Silva, K. N., Khouri, R., Torres, F. G., Meira, C. S., Santos, E. D. S., Macêdo, C. T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073307 · Cited by 55
“MiR-21 also regulates the activity of extracellular signal-regulated kinases (ERK)/MAPK in cardiac fibroblasts by SPRY1 controlling cardiac hypertrophy [21] that could have contributed with the cardiac fibroblasts.”
InfluentialAdding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach
Marracino, L., Fortini, F., Bouhamida, E., Camponogara, F., Severi, P., Mazzoni, E., Patergnani, S., D’Aniello, E., Campana, R., Pinton, P., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.695114 · Cited by 50
HECT Domain-containing E3 Ubiquitin Ligase Nedd4 Interacts with and Ubiquitinates Sprouty2
Edwin, F., Anderson, K. M., & Patel, T. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030882 · Cited by 61
Wang, Y., Xu, F., Chen, J., Shen, X., Deng, Y., Xu, L., Yin, J., Chen, H., Teng, F., Liu, X., et al. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.06.024 · Cited by 52
Majesky, M. W. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308261 · Cited by 54
“miR-21 has many targets whose inhibition effectively promotes growth factor signaling pathways.(55,56) Continuing the theme, Xu et al(57) reported that miR15b/16 inhibits neointimal formation in a rat carotid balloon injury model by promoting the SMC-differentiated phenotype, attenuating arterial SMC migration, and in…”
BackgroundMicroRNAs and their applications in kidney diseases
Badal, S. S., & Danesh, F. R. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2867-7 · Cited by 51
“miR-21 was initially shown to play a role in heart fibrosis [77].”
Fiedler, J., Stoehr, A., Gupta, S. K., Hartmann, D., Holzmann, A., Just, A., Hansen, A., Hilfiker‐Kleiner, D., Eschenhagen, T., & Thum, T. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5418 · Cited by 47
“Endogenous small noncoding microRNAs (miRNAs) are powerful posttranscriptional regulator of various physiological and pathological conditions (17, 21, 22, 24).”
Self-citationHirt, M. N., Werner, T., Indenbirken, D., Alawi, M., Demin, P., Kunze, A.-C., Stenzig, J., Starbatty, J., Hansen, A., Fiedler, J., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.008 · Cited by 47
“We have chosen the well characterized profibrotic miR-21-5p [12] and suppressed it by simple preincubation with an LNA-based anti-miR at a high concentration (similar to that used i.”
MethodSelf-citation
Metadata
- Authors
- Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., Castoldi, M., Soutschek, J., Koteliansky, V., Rosenwald, A., Basson, M. A., Licht, J. D., Pena, J. T. R., Rouhanifard, S. H., Muckenthaler, M. U., Tuschl, T., Martin, G. R., Bauersachs, J., & Engelhardt, S.
- Affiliations
- University of Würzburg (DE)
- Deutsche Forschungsgemeinschaft (DE)
- University of California, San Francisco (US)
- Heidelberg University (DE)
- Regulus Therapeutics (United States) (US)
- Alnylam Pharmaceuticals (United States) (US)
- King's College London (GB)
- Northwestern University (US)
- Rockefeller University (US)
- Technical University of Munich (DE)
- Corresponding author
- Bauersachs, Johann
- Engelhardt, Stefan
- ORCID
- Thum, Thomas
- Gross, Carina
- Fiedler, Jan
- Fischer, Thomas
- Kissler, Stephan
- Galuppo, Paolo
- Just, Steffen
- Rottbauer, Wolfgang
- Frantz, Stefan
- Castoldi, Mirco
- Rosenwald, Andreas
- Basson, M. Albert
- Licht, Jonathan D.
- Pena, John T. R.
- Rouhanifard, Sara H.
- Muckenthaler, Martina U.
- Tuschl, Thomas
- Bauersachs, Johann
- Engelhardt, Stefan
- Venue
- Nature
- Published
- 2008-11-30
- Volume
- 456
- Issue
- 7224
- Pages
- 980-984
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2132093971
- Cited by
- 2,349
- References
- 30
- Citations by year
- 2026: 62 · 2025: 70 · 2024: 71 · 2023: 76 · 2022: 106 · 2021: 131 · 2020: 151 · 2019: 138 · 2018: 153 · 2017: 167 · 2016: 150 · 2015: 200 · 2014: 183 · 2013: 203 · 2012: 176
- FWCI
- 75.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- National Cancer Institute (R01CA078711, R01 CA 78711, R01CA059998)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-21, cardiac fibroblasts, heart failure, SPRY1, interstitial fibrosis, cardiac hypertrophy, microRNA silencing, antagomir, fibroblast survival, therapeutic target, cardiomyocytes
- MeSH terms
- Animals, Cell Line, Cell Survival, Cells, Cultured, Disease Models, Animal, Fibroblasts, Humans, Male, Mice, Transgenic, Cardiomyopathies, Gene Silencing, MAP Kinase Signaling System, Myocytes, Cardiac, MicroRNAs, Extracellular Signal-Regulated MAP Kinases, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.